Evidence map›Paper›PMID 23532670›Full record

ArticleImmunologic research2013

Potential regulatory role of in vitro-expanded Vδ1 T cells from human peripheral blood.

Fang Hua, Ning Kang, Yun-An Gao, Lian-Xian Cui, De-Nian Ba, Wei He

Abstract read
PubMed Publisher
In one paragraph

Article in Immunologic research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Regulatory functions of γδ T cells.Cellular and molecular life sciences : CMLS · 2018
    Review
  11. Article
  12. Review
  13. Potential Role of Vδ2Frontiers in immunology · 2017
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Oncoimmunology · 2015
    Article
  19. Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells.Clinical cancer research : an official journal of the American Association for Cancer Research · 2014
    Article
  20. Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field?Molecular therapy : the journal of the American Society of Gene Therapy · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Fang HuaDepartment of Immunology, School of Basic Medicine, Peking Union Medical College, National Key Laboratory of Medical Molecular Biology, Chinese Academy of Medical Sciences, Beijing, China. huafang82@163.com
Ning Kang
Yun-An Gao
Lian-Xian Cui
De-Nian Ba
Wei He
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

γδ T cells represent a relevant proportion of T lymphocytes that express T cell receptors (TCRs) encoded by the γ and δ T cell receptor genes. Whereas the most circulating γδ T cell type, Vδ2 T cells, has been described and studied intensively, the potential role of Vδ1 T cells remains largely unclear. Here, we identified that expanded peripheral blood Vδ1 T cells stimulated with anti-human TCR Vδ1 monoclonal antibody (mAb) in vitro predominantly expressed forkhead box p3 (Foxp3). In addition, these cells also expressed other regulatory T cell-related molecules, such as CD25, glucocorticoid-induced TNFR family-related protein and cytotoxic T lymphocyte-associated protein-4 (CTLA-4), and held the potent capacity for the production of transforming growth factor beta 1 (TGF-β1). These autocrine and/or paracrine TGF-β1 could bind TGF-β1 receptors on Vδ1 T cells and induce sustained Foxp3 expression. Moreover, Foxp3 expression coincided with high CD25 expression. CD25(high) Vδ1 T cells exhibited stronger suppression on CD4(+) T cell proliferation compared with TGF-β1-induced CD25(high) CD4(+) regulatory T cells. Therefore, our phenotypic and functional analyses first demonstrate the potential regulatory property of anti-human TCR Vδ1 mAb-activated Vδ1 T cells. These results will broaden our understanding about the role of peripheral blood Vδ1 T cells under physical and pathological conditions.

Indexed as

AdultAntibodies, MonoclonalBlood CellsBlood CirculationCell ProliferationCells, CulturedCTLA-4 AntigenForkhead Transcription FactorsHumansImmunosuppression TherapyInterleukin-2 Receptor alpha SubunitReceptors, Antigen, T-Cell, gamma-deltaT-Lymphocytes, RegulatoryTransforming Growth Factor beta1Young AdultAntibodies, MonoclonalCTLA-4 AntigenForkhead Transcription FactorsFOXP3 protein, humanInterleukin-2 Receptor alpha SubunitReceptors, Antigen, T-Cell, gamma-deltaT-cell receptor Vdelta2, humanTransforming Growth Factor beta1

Identifiers

PMID23532670
OpenAlexW2089469111

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.